Microbiology and Biotechnology Letters (한국미생물·생명공학회지)

The Korean Society for Microbiology and Biotechnology (한국미생물·생명공학회)
권호 표지
DOI QR코드

DOI QR Code

Development of a Blocking ELISA for Measuring Rabies Virus-specific Antibodies in Animals

  • Yang, Dong-Kun (Viral Disease Research Division,Animal and Plant Quarantine Agency, MAFRA) ;
  • Kim, Ha-Hyun (Viral Disease Research Division,Animal and Plant Quarantine Agency, MAFRA) ;
  • Ryu, Jieun (Bionote) ;
  • Gee, Mi-ryun (Viral Disease Research Division,Animal and Plant Quarantine Agency, MAFRA) ;
  • Cho, In-Soo (Viral Disease Research Division,Animal and Plant Quarantine Agency, MAFRA)
  • Received : 2018.05.01
  • Accepted : 2018.06.01
  • Published : 2018.09.28
Download PDF
⟨ Previous Next ⟩

Abstract

Rabies virus (RABV)-specific antibodies in animals and humans are measured using standard methods such as fluorescent antibody virus neutralization (FAVN) tests and rapid fluorescent focus inhibition tests, which are based on cell culture systems. An alternative assay that is safe and easy to perform is required for rapid sero-surveillance following mass vaccination of animals. Two purified monoclonal antibodies (4G36 and B2H17) against RABV were selected as capture and detection antibodies, respectively. A genetically modified RABV, the ERAGS strain, was propagated and concentrated by polyethylene glycol precipitation. Optimal conditions for the RABV antigen, antibodies, and serum dilution for a blocking enzymelinked immune sorbent assay (B-ELISA) were established. We evaluated the sensitivity, specificity, and accuracy of the B-ELISA using serum samples from 138 dogs, 71 raccoon dogs, and 25 cats. The B-ELISA showed a diagnostic sensitivity of 95.8-96.3%, specificity of 91.3-100%, and accuracy of 96.0-97.2% compared to the FAVN test. These results suggest that the B-ELISA is useful for sero-surveillance of RABV in dogs, raccoon dogs, and cats.

Keywords

References

  1. Cheong Y, Kim B, Lee KJ, Park D, Kim S, Kim H, et al. 2014. Strategic model of national rabies control in Korea. Clin. Exp. Vaccine Res. 3: 78-90. https://doi.org/10.7774/cevr.2014.3.1.78
  2. Yang DK, Kim HH, Lee KK, Yoo JY, Seomun H, Cho IS. 2017. Mass vaccination has led to the elimination of rabies since 2014 in South Korea. Clin. Exp. Vaccine Res. 6: 111-119. https://doi.org/10.7774/cevr.2017.6.2.111
  3. Cliquet F, Aubert M, Sagne L. 1998. Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody. J. Immunol. Methods. 212: 79-87. https://doi.org/10.1016/S0022-1759(97)00212-3
  4. Fitzgerald E. 1996. Potency test for antirabies serum and immunoglobulin. Laboratory Techniques in Rabies 4: 417-422.
  5. Smith JS, Yager PA, Baer GM. 1973. A rapid reproducible test for determining rabies neutralizing antibody. Laboratory Techniques in Rabies. 4: 181-192.
  6. Muhamuda K, Madhusudana SN, Ravi V. 2007. Development and evaluation of a competitive ELISA for estimation of rabies neutralizing antibodies after post-exposure rabies vaccination in humans. Int. J. Infect. Dis. 11: 441-445. https://doi.org/10.1016/j.ijid.2006.09.013
  7. He Y, Gao D, Zhang M. 2006. Expression of the nucleoprotein gene of rabies virus for use as a diagnostic reagent. J. Virol. Methods. 138: 147-151. https://doi.org/10.1016/j.jviromet.2006.08.006
  8. Inoue S, Motoi Y, Kashimura T, Ono K, Yamada A. 2003. Safe and easy monitoring of anti-rabies antibody in dogs using his-tagged recombinant N-protein. Jpn. J. Infect. Dis. 56: 158-160.
  9. Kucinskaite I, Juozapaitis M, Serva A, Zvirbliene A, Johnson N, Staniulis J, et al. 2007. Antigenic characterisation of yeastexpressed lyssavirus nucleoproteins. Virus Genes. 35: 521-529. https://doi.org/10.1007/s11262-007-0127-7
  10. Reid-Sanden FL, Sumner JW, Smith JS, Fekadu M, Shaddock JH, Bellini WJ. 1990. Rabies diagnostic reagents prepared from a rabies N gene recombinant expressed in baculovirus. J. Clin. Microbiol. 28: 858-863.
  11. Sugiyama M, Yoshiki R, Tatsuno Y, Hiraga S, Itoh O, Gamoh K, et al. 1997. A new competitive enzyme-linked immunosorbent assay demonstrates adequate immune levels to rabies virus in compulsorily vaccinated Japanese domestic dogs. Clin. Diagn. Lab. Immunol. 4: 727-730.
  12. Yang DK, Kim HH, Lee SH, Ji M, Cho IS. 2017. Indirect ELISA for the Detection of Rabies Virus Antibodies in Dog Sera. J. Bacteriol. Virol. 47: 148. https://doi.org/10.4167/jbv.2017.47.3.148
  13. World Organization for Animal Health (OIE). 2012. Manual of diagnostic tests and vaccines for terrestrial animals, pp 263-282. 7th Ed.
  14. Reed LJ, Muench H. 1938. A simple method of estimating fifty per cent endpoints. Am. J. Epidemiol. 27: 493-497. https://doi.org/10.1093/oxfordjournals.aje.a118408
  15. Lewis GD, Metcalf TG. 1988. Polyethylene glycol precipitation for recovery of pathogenic viruses, including hepatitis A virus and human rotavirus, from oyster, water, and sediment samples. Appl. Environ. Microbiol. 54: 1983-1988.
  16. Nakane PK, Kawaoi A. 1974. Peroxidase-labeled antibody. A new method of conjugation. J. Histochem. Cytochem. 22: 1084-1091. https://doi.org/10.1177/22.12.1084
  17. Franka R, Smith TG, Dyer JL, Wu X, Niezgoda M, Rupprecht CE. 2013. Current and future tools for global canine rabies elimination. Antiviral. Res. 100: 220-225. https://doi.org/10.1016/j.antiviral.2013.07.004
  18. Cliquet F, McElhinney LM, Servat A, Boucher JM, Lowings JP, Goddard T, et al. 2004. Development of a qualitative indirect ELISA for the measurement of rabies virus-specific antibodies from vaccinated dogs and cats. J. Virol. Methods. 117: 1-8. https://doi.org/10.1016/j.jviromet.2003.12.001
  19. Knoop EV, Freuling CM, Kliemt J, Selhorst T, Conraths FJ, Muller T. 2010. Evaluation of a commercial rabies ELISA as a replacement for serum neutralization assays as part of the pet travel scheme and oral vaccination campaigns of foxes. Berl. Munch. Tierarztl Wochenschr. 123: 278-285.
  20. Esterhuysen JJ, Prehaud C, Thomson GR. 1995. A liquid-phase blocking ELISA for the detection of antibodies to rabies virus. J. Virol. Methods. 51: 31-42. https://doi.org/10.1016/0166-0934(94)00098-2

Cited by

  1. Immunogenicity of an inactivated rabies vaccine for animals derived from the recombinant ERAGS strain vol.10, pp.2, 2018, https://doi.org/10.7774/cevr.2021.10.2.141